Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models

Amiselimod (MT-1303) is a novel and selective sphingosine 1-phosphate receptor-1 (S1P(1)) modulator with a more favorable cardiac safety profile than other S1P(1) receptor modulators. In this study, we evaluated the effects of MT-1303 on the progression of lupus nephritis in two well-known murine sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugahara, Kunio, Maeda, Yasuhiro, Shimano, Kyoko, Murase, Mikako, Mochiduki, Sachiko, Takemoto, Kana, Kakimoto, Tetsuhiro, Utsumi, Hiroyuki, Oshita, Koichi, Kataoka, Hirotoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942851/
https://www.ncbi.nlm.nih.gov/pubmed/31930150
http://dx.doi.org/10.1155/2019/5821589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942851/
https://www.ncbi.nlm.nih.gov/pubmed/31930150
http://dx.doi.org/10.1155/2019/5821589

Ejemplares similares